SanBio Company Limited
SanBio Company Limited engages in the development, production, and sale of regenerative cell medicines for the central nervous system. It develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. The company's research pipeline products also comprise SB623 for chronic cerebral infarction and chronic traumatic cerebral infarction inj… Read more
Market Cap & Net Worth: SanBio Company Limited (SNBIF)
SanBio Company Limited (OTCGREY:SNBIF) has a market capitalization of $511.08 Million ($511.08 Million) as of March 18, 2026. Listed on the OTCGREY stock exchange, this USA-based company holds position #11998 globally and #5243 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SanBio Company Limited's stock price $6.55 by its total outstanding shares 78027793 (78.03 Million).
SanBio Company Limited Market Cap History: 2015 to 2025
SanBio Company Limited's market capitalization history from 2015 to 2025. Data shows growth from $9.67K to $511.08 Million (216.58% CAGR).
SanBio Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SanBio Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
33.25x
SanBio Company Limited's market cap is 33.25 times its annual revenue
1742.66x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $12.78K | $1.17 Billion | -$988.00 Million | 0.00x | N/A |
| 2017 | $32.77K | $949.00 Million | -$1.83 Billion | 0.00x | N/A |
| 2018 | $89.72K | $490.00 Million | -$3.94 Billion | 0.00x | N/A |
| 2019 | $42.50K | $741.61 Million | -$2.92 Billion | 0.00x | N/A |
| 2020 | $82.54 Million | $447.23 Million | -$5.16 Billion | 0.18x | N/A |
| 2021 | $760.77 Million | $22.88 Million | -$3.39 Billion | 33.25x | N/A |
Competitor Companies of SNBIF by Market Capitalization
Companies near SanBio Company Limited in the global market cap rankings as of March 18, 2026.
Key companies related to SanBio Company Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
SanBio Company Limited Historical Marketcap From 2015 to 2025
Between 2015 and today, SanBio Company Limited's market cap moved from $9.67K to $ 511.08 Million, with a yearly change of 216.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $511.08 Million | +70.13% |
| 2024 | $300.41 Million | -2.53% |
| 2023 | $308.21 Million | -28.96% |
| 2022 | $433.83 Million | -42.97% |
| 2021 | $760.77 Million | +821.72% |
| 2020 | $82.54 Million | +194116.67% |
| 2019 | $42.50K | -52.63% |
| 2018 | $89.72K | +173.81% |
| 2017 | $32.77K | +156.31% |
| 2016 | $12.78K | +32.14% |
| 2015 | $9.67K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of SanBio Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $511.08 Million USD |
| MoneyControl | $511.08 Million USD |
| MarketWatch | $511.08 Million USD |
| marketcap.company | $511.08 Million USD |
| Reuters | $511.08 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.